Pfizer New FDA Restriction - Search News

Pfizer to seek FDA approval for Lyme vaccine

Pfizer to seek FDA approval for Lyme vaccine as CT report shows ticks are more abundant than ever

With ticks carrying Lyme disease more abundant than ever in Connecticut, a major drug company is moving forward with a vaccine for the ailment despite some mixed results in a new clinical trial.

Continue reading

The Cool Down on MSN · 1d

Pfizer seeks FDA approval for new Lyme disease vaccine candidate

· 1d · on MSN

Pfizer to seek FDA approval for Lyme disease vaccine candidate despite trial miss

Pfizer Lyme Disease Vaccine Shows 70% Efficacy, But Misses Statistical Goal

Pfizer and Valneva said on Monday their Lyme disease vaccine showed more than 70% efficacy in a late-stage study, even as it missed its main goal.

Continue reading

Pfizer’s Lyme Vaccine Misses Mark in Study, Complicating Quest for Approval

Pfizer says Lyme disease vaccine is holding promise